__NUXT_JSONP__("/drugs/Veltuzumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"728917-18-8",chebiId:b,chemicalFormula:b,definition:"A humanized monoclonal antibody directed against the CD20 antigen with potential antineoplastic activity. Following binding, veltuzumab triggers complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) in cells that overexpress CD20. CD20 antigen is a hydrophobic transmembrane protein located on pre-B and mature B lymphocytes.",fdaUniiCode:"BPD4DGQ314",identifier:"C48406",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C141215"],synonyms:["Anti-CD20 Monoclonal Antibody hA20","HCD20","IMMU-106","MoAb hA20","Monoclonal Antibody hA20","VELTUZUMAB",a,"hA20","veltuzumab"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FVeltuzumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Veltuzumab","","2021-10-30T13:40:13.203Z")));